mrna moderna - Search News

Moderna, RSV

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

RESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted

Business Insider · 1h

Moderna receives MHRA marketing authorization for RSV vaccine

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for

Reuters · 6h

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 years and older.

Vietnam Investment Review on M… · 1d

AIM Vaccine s mRNA RSV Vaccine Approved for U S Clinical Trials

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) HONG KONG,

Moderna, HHS and bird flu

MarketWatch · 23h

Moderna’s stock stumbles on report HHS is reviewing $590 million award for bird-flu vaccine

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Reuters · 1d

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

The Hill on MSN · 20h

HHS weighs rescinding Moderna bird flu vaccine contract

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in the waning days of the Biden administration. “While it is crucial

Hosted on MSN8h

Moderna Stock Heads For Weekly Loss As Retail Caution Prevails: Wealth Advisor Tells Why She's Staying On The Sidelines

Shares of Moderna Inc. (MRNA) are on track for a more than 12% weekly decline, with sentiment among retail traders turning ...

BioSpace11hOpinion

Opinion: How mRNA Can Help Bridge the Innovation Gap in Rare Disease

As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...

Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

Hosted on MSN3h

Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...

9don MSN

Why Moderna (MRNA) Went Up on Tuesday?

We recently published a list of 10 Firms Kick Off Shortened Trading Week With Impressive Gains. In this article, we are going ...

Moderna, Inc.: Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results